Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.28 USD
Change Today 0.00 / 0.00%
Volume 1.3M
IMGN On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John M. Lambert Ph.D.

Executive Vice President of Distinguished Research Fellow,ImmunoGen, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. John M. Lambert Ph.D., has been an Executive Vice President of Distinguished Research Fellow ImmunoGen, Inc. since July 2008. Dr. Lambert joined ImmunoGen Inc., in 1987 and served as a Senior Vice President of Pharmaceutical Development from 2000 to July 2008. Dr. Lambert served as Senior Director of Research at Immunogen Inc., from October 1994 to November 1996. He served as Chief Scientific Officer and Executive Vice President of Research at ImmunoGen, Inc. from ...

Read Full Background

Corporate Headquarters*

830 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-895-0600
Fax: 781-895-0611

Board Members Memberships*

There is no Board Members Memberships data available.


PhD 1987
University of Cambridge
Unknown/Other Education
University of California, Davis
Unknown/Other Education
University of Glasgow Scotland

Other Affiliations*

Annual Compensation*

Total Annual Compensation$377,200

Stock Options*

All Other Compensation$8,184
Exercised Options35,000
Exercised Options Value$349,605
Exercisable Options452,501
Exercisable Options Value$1,738,375
Unexercisable Options199,999
Total Value of Options$2,087,980
Total Number of Options687,500

Total Compensation*

Total Annual Cash Compensation$528,720
Total Short Term Compensation$377,200
Other Long Term Compensation$8,184
Total Calculated Compensation$1,625,566
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $14.28 USD 0.00


Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
Nobuo Hanai Ph.D.Chief Executive Officer, President and Representative Director
Kyowa Hakko Kirin Co., Ltd.
Edwin Moses Ph.D.Chief Executive Officer, Director and Member of Research & Development Committee
Ablynx NV
William John Edward Burt DPhilChief Executive Officer and Executive Director
Abzena plc
255.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at